144 related articles for article (PubMed ID: 3612295)
1. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
[TBL] [Abstract][Full Text] [Related]
2. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
3. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].
Schümichen C; Bulczak-Schmidt M; Blattmann H; Pauli-Harnasch C
Nuklearmedizin; 1984 Oct; 23(5):265-9. PubMed ID: 6522276
[TBL] [Abstract][Full Text] [Related]
5. Treatment of thyroid carcinoma: emphasis on high-dose 131I outpatient therapy.
Parthasarathy KL; Crawford ES
J Nucl Med Technol; 2002 Dec; 30(4):165-71; quiz 172-3. PubMed ID: 12446749
[TBL] [Abstract][Full Text] [Related]
6. Leukemia after a small dose of radioiodine for metastatic thyroid cancer.
Bitton R; Sachmechi I; Benegalrao Y; Schneider BS
J Clin Endocrinol Metab; 1993 Nov; 77(5):1423-6. PubMed ID: 8077344
[TBL] [Abstract][Full Text] [Related]
7. Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.
Saint-Vil D; Emran MA; Lambert R; Alos N; Turpin S; Huot C
J Pediatr Surg; 2007 May; 42(5):853-6. PubMed ID: 17502198
[TBL] [Abstract][Full Text] [Related]
8. Complications, sequela and dosimetry of iodine-131 therapy for thyroid carcinoma.
Bushnell DL; Boles MA; Kaufman GE; Wadas MA; Barnes WE
J Nucl Med; 1992 Dec; 33(12):2214-21. PubMed ID: 1460519
[No Abstract] [Full Text] [Related]
9. [Radioiodide therapy in pulmonary metastasis of differentiated thyroid cancer--factors affecting the success of I-131 therapy].
Takada Y; Ohta Y; Kawasaki S; Maki M; Hiroe M; Kusakabe K; Shigeta A; Yamazaki T; Fujimoto Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Jul; 47(7):962-70. PubMed ID: 3658666
[No Abstract] [Full Text] [Related]
10. Subsequent malignancies in patients treated with 131-iodine for thyroid cancer.
Glanzmann C
Strahlenther Onkol; 1992 Jun; 168(6):337-43. PubMed ID: 1621212
[TBL] [Abstract][Full Text] [Related]
11. Acute leukemias after treatment with radioiodine for thyroid cancer.
Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
[TBL] [Abstract][Full Text] [Related]
12. An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.
Beierwaltes WH; Rabbani R; Dmuchowski C; Lloyd RV; Eyre P; Mallette S
J Nucl Med; 1984 Dec; 25(12):1287-93. PubMed ID: 6502251
[TBL] [Abstract][Full Text] [Related]
13. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
Sarkar SD; Beierwaltes WH; Gill SP; Cowley BJ
J Nucl Med; 1976 Jun; 17(6):460-4. PubMed ID: 944243
[TBL] [Abstract][Full Text] [Related]
14. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
Shimon I; Kneller A; Olchovsky D
Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
[TBL] [Abstract][Full Text] [Related]
15. Hyperthyroidism with metastatic follicular thyroid carcinoma.
Chapman CN; Sziklas JJ; Spencer RP; Bower BF; Rosenberg RJ
J Nucl Med; 1984 Apr; 25(4):466-8. PubMed ID: 6152721
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the efficacy of iodine-131 for thyroid ablation.
Comtois R; Thériault C; Del Vecchio P
J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
[TBL] [Abstract][Full Text] [Related]
17. Iodine-131 in breast milk following therapy for thyroid carcinoma.
Robinson PS; Barker P; Campbell A; Henson P; Surveyor I; Young PR
J Nucl Med; 1994 Nov; 35(11):1797-801. PubMed ID: 7965159
[TBL] [Abstract][Full Text] [Related]
18. [Acute lymphoblastic leukemia with t(4;11)(q21;q23) after iodine-131 treatment for thyroid cancer].
Iuchi Y; Sato K; Jimbo J; Inamura J; Shindo M; Ikuta K; Shinzaki H; Ohnishi K; Watanabe S; Torimoto Y; Kohgo Y
Rinsho Ketsueki; 2005 Nov; 46(11):1202-7. PubMed ID: 16440804
[TBL] [Abstract][Full Text] [Related]
19. [Dosimetry of the hematopoietic system in radioiodine therapy of thyroid cancer].
Günter HH; Junker D; Schober O; Hundeshagen H
Strahlenther Onkol; 1987 Mar; 163(3):185-91. PubMed ID: 3563879
[TBL] [Abstract][Full Text] [Related]
20. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
